Loving the idea of no more liquid nitrogen buckets. VitriGen’s mechanical cooling saves time and keeps things sterile. It’s a convenient upgrade for busy labs wanting to avoid LN2 contamination risks entirely.
Questions about VitriGen by E-Cryogenics
What is VitriGen by E-Cryogenics?
VitriGen by E-Cryogenics is a medical device company that produces a mechanical vitrification system for IVF laboratories. The patented system replaces liquid nitrogen by reaching −221°C on a sterile, single-use surface to address contamination risks and safety hazards. The company holds US Patent 12,588,674 B2 and cites over 52 peer-reviewed studies on sterile surface vitrification since 2002.
What specific problems does the mechanical vitrification system solve?
The system is designed for oocyte and embryo cryopreservation in IVF laboratories. It specifically addresses contamination risks from shared liquid nitrogen dewars, vapor temperature gradients during cooling, and the safety hazards of direct-plunge handling. This sterile, single-use surface approach aims to improve safety and hygiene in the lab environment.
How does the patented cryogenic cooler technology function?
The device operates by reaching a temperature of −221°C on a sterile, single-use surface. This mechanical cooling system is patented under US Patent 12,588,674 B2 and is intended to replace traditional liquid nitrogen methods. The technology relies on a patented cryogenic cooler to achieve these extreme temperatures without liquid nitrogen.
What is the current Trustburn rating and how can I see the system in action?
Trustburn shows a rating of 4.3 out of 5 from 4 reviews. The company invites users to schedule a live demonstration to learn more about the product. This interactive option allows potential customers to see the system in action before purchasing.
What is the official website of VitriGen by E-Cryogenics?
The official website of VitriGen by E-Cryogenics is ecryogenics.com.
AI-generated from reviews on this page. Verify anything important with the company directly.
VitriGen offers a distinct approach to vitrification by removing liquid nitrogen from the workflow entirely. The system utilizes a mechanical cooler to achieve temperatures around negative two hundred twenty-one degrees Celsius, which is approximately twenty degrees colder than standard LN2. This eliminates the need for open dewars, thereby reducing contamination risks associated with shared liquid nitrogen and vapor gradients. The use of a single-use sterile surface for each patient further minimizes cross-contamination potential. The technology is supported by US Patent 12,588,674 B2, which covers the gas-purged mechanical cooling architecture. The system employs an inert gas purge to prevent frost formation on the cold finger, ensuring a consistent cooling surface. While solid surface vitrification has been studied since 2002, VitriGen introduces a new cooling source. The Cryo-Pulse 5 Plus unit has a stated mean time to failure of 340 years, which is a notable specification. The system addresses handler safety concerns by removing the need for direct plunging into open containers, reducing asphyxiation risks. However, the reliance on specific inert gases like helium or argon may introduce additional supply chain considerations. The transition from traditional methods requires training, though the direct-contact technique remains familiar to embryologists. Overall, VitriGen presents a viable alternative for labs seeking to eliminate LN2 contamination vectors while maintaining established vitrification protocols.
The mechanical cooling approach removes LN2 contamination risks effectively. While the patent details are clear, the long-term maintenance costs for the cryocooler remain unclear for smaller clinics.
VitriGen looks like a solid upgrade for any lab. Replacing liquid nitrogen entirely removes the contamination risk from open buckets. The sterile single-use surface is a smart move, and reaching those deep temperatures without LN2 seems like a genuine advancement for embryo safety.
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About VitriGen by E-Cryogenics
VitriGen by E-Cryogenics is a medical device company that produces a mechanical vitrification system used in IVF laboratories. The product is designed to replace liquid nitrogen in oocyte and embryo cryopreservation with a patented mechanical cooling system that reaches −221°C on a sterile, single-use surface. It addresses contamination risks associated with shared liquid nitrogen dewars, vapor temperature gradients during cooling, and the safety hazards of direct-plunge handling. The company holds US Patent 12,588,674 B2 for its cryogenic cooler technology and cites over 52 peer-reviewed studies on sterile surface vitrification since 2002. The website invites users to schedule a live demonstration and references an upcoming industry meeting at ASRM 2026.
- Website
- ecryogenics.com
- Categories
- Hospital & health care, Computer software, Medical devices